Med. praxi. 2025;22(1):44-47 | DOI: 10.36290/med.2025.002

Pharmacotherapy in pregnancy - striving for balance

MUDr. Roman Chmel, Ph.D.
Gynekologicko‑porodnická klinika 2. LF UK a FN Motol, Praha

The basic prerequisite for safe pharmacotherapy during pregnancy is a knowledge of the specifics that apply to the individual trimesters of pregnancy. This review article presents the main principles of pharmacotherapy of the most common diseases in pregnancy.

Keywords: pharmacotherapy, pregnancy, teratogenicity, hypertension, diabetes, epilepsy, antibiotics.

Received: December 18, 2024; Revised: December 18, 2024; Accepted: January 21, 2025; Published: February 20, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chmel R. Pharmacotherapy in pregnancy - striving for balance. Med. praxi. 2025;22(1):44-47. doi: 10.36290/med.2025.002.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 20.2.2026

    References

    1. Lupattelli A, Spigset O, Twigg MJ, et al. Medication use in pregnancy: a cross­‑sectional, multinational web­‑based study. BMJ Open. 2014;4(2):e004365. doi:10.1136/bmjopen-2013-004365. Go to original source... Go to PubMed...
    2. Mitchell AA, Gilboa SM, Werler MM, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011;205(1):51.e1-51.e518. doi:10.1016/j.ajog.2011. 02. 029. Go to original source...
    3. Byrne JJ, Saucedo AM, Spong CY. Evaluation of drug labels following the 2015 Pregnancy and Lactation Labeling Rule. JAMA Netw Open. 2020;3(8):e2015094. doi:10.1001/jamanetworkopen.2020.15094. Go to original source... Go to PubMed...
    4. Wilmer E, Chai S, Kroumpouzos G. Drug safety: Pregnancy rating classifications and controversies. Clin Dermatol. 2016;34(3):401-409. doi:10.1016/j.clindermatol.2016. 02. 013. Go to original source...
    5. Kocourková J, Šťastná A, Idlbeková B, et al. Trendy plodnosti a potratovosti v Česku. Cas Lek Cesk. 2024;162(7-8):299-306.
    6. Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. BMJ. 2023;381:e071653. doi:10.1136/bmj-2022-071653. Go to original source... Go to PubMed...
    7. Guedes­‑Martins L. Superimposed preeclampsia. Adv Exp Med Biol. 2017;956:409-417. doi:10.1007/5584_2016_82. Go to original source... Go to PubMed...
    8. Roubalová L, Vojtěch J, Feyereisl J, et al. Screening preeklampsie v I. trimestru těhotenství. Ceska Gynekol. 2019;84(5):361-370.
    9. Krejčí H, Andělová K, Anderlová K, et al. Gestační diabetes mellitus. Mezioborová spolupráce. Ceska Gynekol. 2018;83(5):397-406.
    10. Brand KMG, Saarelainen L, Sonajalg J, et al. Metformin in pregnancy and risk of adverse long­‑term outcomes: a register­‑based cohort study. BMJ Open Diabetes Res Care. 2022;10(1):e002363. doi:10.1136/bmjdrc-2021-002363. Go to original source... Go to PubMed...
    11. Newman C, Dunne FP. Metformin for pregnancy and beyond: the pros and cons. Diabet Med. 2022;39(3):e14700. doi:10.1111/dme.14700. Go to original source... Go to PubMed...
    12. Molin J, Domellöf M, Häggström C, et al. Neonatal outcome following metformin­‑treated gestational diabetes mellitus: a population­‑based cohort study. Acta Obstet Gynecol Scand. 2024;103(5):992-1007. doi:10.1111/aogs.14787. Go to original source... Go to PubMed...
    13. Guo L, Ma J, Tang J, et al. Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta­‑analysis. J Diabetes Res. 2019;2019:9804708. doi:10.1155/2019/9804708. Go to original source... Go to PubMed...
    14. Procházka M, Velebil P, Binder T, et al. Porod velkého plodu. Ceska Gynekol. 2016;81(2):125-128.
    15. Rao M, Zeng Z, Zhou F, et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta­‑analysis. Hum Reprod Update. 2019;25(3):344-361. doi:10.1093/humupd/dmz003. Go to original source... Go to PubMed...
    16. Maraka S, Ospina NM, O'Keeffe DT, et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta­‑analysis. Thyroid. 2016;26(4):580-590. doi:10.1089/thy.2015.0418. Go to original source... Go to PubMed...
    17. Kobaly K, Mandel SJ. Hyperthyroidism and pregnancy. Endocrinol Metab Clin North Am. 2019;48(3):533-545. doi:10.1016/j.ecl.2019. 05. 002. Go to original source...
    18. Zárubová J. Epilepsie, těhotenství a kojení. Neurol. pro praxi. 2010;11(5):292-296.
    19. Bookstaver PB, Bland CM, Griffin B, et al. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015;35(11):1052-1062. doi:10.1002/phar.1649. Go to original source... Go to PubMed...
    20. Andersen JT, Petersen M, Jimenez­‑Solem E, et al. Trimethoprim use prior to pregnancy and the risk of congenital malformation: a register­‑based nationwide cohort study. Obstet Gynecol Int. 2013;2013:364526. doi:10.1155/2013/364526. Go to original source... Go to PubMed...
    21. Nosková P. Léčba bolesti během gravidity a laktace. Med. praxi. 2011;8(9):370-373.
    22. Price HR, Collier AC. Analgesics in Pregnancy: an update on use, safety and pharmacokinetic changes in drug disposition. Curr Pharm Des. 2017;23(40):6098-6114. doi:10.2174/1381612823666170825123754. Go to original source... Go to PubMed...
    23. Turankar T, Sorte A, Wanjari MB, et al. Relation and treatment approach of migraine in pregnancy and breastfeeding. Cureus. 2023;15(3):e36828. doi:10.7759/cureus.36828. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.